Stocktoria
VERU INC. VERU
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 1990-07-19
VERU INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | $16.9M | $16.3M | $39.4M | $61.3M |
| Gross profit | — | $5.9M | $7.6M | $30.6M | $47.9M |
| R&D expense | $15.6M | $12.8M | $51.2M | $70.6M | $32.7M |
| SG&A expense | — | $31.2M | $48.1M | $43.2M | $20.7M |
| Operating income | -$24.8M | -$36.2M | -$93.8M | -$83.2M | $13.0M |
| Interest expense | — | — | $2.4M | $4.4M | $4.9M |
| Income tax | $0 | $0 | $480,206 | $236,397 | -$3.1M |
| Net income | -$22.7M | -$37.8M | -$93.2M | -$83.8M | $7.4M |
| EPS (diluted) | — | — | $-1.10 | $-1.05 | $0.09 |
| Operating cash flow | -$30.0M | -$21.7M | -$88.0M | -$47.5M | -$15.6M |
| Free cash flow | -$30.0M | -$21.8M | -$88.7M | -$48.2M | -$15.9M |
| Cash & equivalents | $15.8M | $24.9M | $9.6M | — | — |
| Inventory | — | $4.1M | $6.7M | $8.6M | $5.6M |
| Total assets | $29.8M | $60.4M | $50.0M | $136.1M | $178.1M |
| Total liabilities | $11.5M | $28.1M | $30.3M | $55.3M | $25.9M |
| Shareholders' equity | $18.3M | $32.3M | $19.7M | $82.8M | $152.3M |
Source: SEC EDGAR filings · CIK 0000863894 · as of 2025-09-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.